The most consequential number in Refills’ public documentation may not be its advertised starting price of $5 a day. For someone deciding whether to subscribe, the more actionable number is 72 hours: the cancellation cutoff in its terms before the applicable monthly processing date. That deadline sits alongside an FAQ promising that customers can pause, skip or cancel anytime. Those statements are not interchangeable, and understanding their relationship matters before a payment method is attached to an ongoing prescription service.
Refills documents a real virtual weight-management offering, including compounded semaglutide injections and a separately described Personalized GIP + GLP-1 injectable plan. But it identifies itself as a technology platform, with independent clinicians and pharmacies responsible for other parts of the service. This review examines public documentation consulted October 19, 2026, focusing on what enrollment appears to authorize, what the advertised price does not establish, and which responsibilities need written clarification. It does not assess individual treatment suitability or verify the company’s clinical or quality claims.
At a glance
- Starting price
- Both injectable product pages advertise prices as low as $5 a day, without establishing the billed total, billing period or supply duration in those advertisements.
- Automatic renewal
- Subscription purchases authorize recurring charges at intervals disclosed during checkout, continuing until cancellation.Sources: [5]
- Cancellation deadline
- The terms specify cancellation up to 72 hours before the applicable monthly processing date, despite broader anytime-cancellation language in the FAQ.
- Separate service providers
- Refills describes itself as a technology platform rather than a medical provider; independent professional entities and pharmacies supply clinical and dispensing services.
Start with the renewal authorization, not the quiz
Refills markets a three-minute quiz, but that is not the contractual measure of what happens next. Its terms say that purchasing a subscription authorizes automatic charges to the selected payment method at the recurring intervals disclosed during checkout. Those charges continue unless and until the subscription is canceled. The public price advertisements do not establish that interval themselves, so the checkout disclosure is essential rather than a minor administrative detail. A short intake also does not guarantee approval: prescribing remains a clinician’s decision.
The cancellation language deserves particular attention. The terms allow cancellation up to 72 hours before the applicable monthly processing date, through the account at app.refills.com or by email. The FAQ, by contrast, says customers can pause, skip or cancel anytime through the dashboard, without penalties or long-term commitments. It also promises a reminder email before every upcoming charge. That reminder promise does not state how far in advance it arrives or replace the explicit cancellation cutoff.
Before enrolling, ask which date controls the next charge and what happens if a cancellation request arrives inside the 72-hour window. Save the answer and the checkout terms, along with confirmation of any later cancellation. The practical distinction is between ending future renewals and stopping a payment or pharmacy order already in progress. Our guide to cancellation notice and renewal dates explains why those events should be checked separately rather than treated as one action.
| Issue | What Refills documents | What to confirm in writing |
|---|---|---|
| Renewal | Automatic charges at checkout-disclosed intervals | Exact amount, interval and next processing date |
| Cancellation | Terms specify a 72-hour cutoff | How the cutoff applies to pending orders |
| Pausing or skipping | FAQ says these are available in the dashboard | Effect on the next charge and prescription order |
| Refunds | Reviewed documentation does not establish refund conditions | Rules for charged, processed or dispensed orders |
| Reminders | FAQ promises an email before each charge | How much notice the reminder provides |
A daily headline is not a complete purchase price
Both the Personalized GLP-1 and Personalized GIP + GLP-1 pages advertise prices as low as $5 per day, alongside free shipping and no insurance requirement. That is a starting-price claim, not a documented monthly bill. The advertisements do not identify the total collected, billing period, supply duration, minimum commitment or any associated prepayment. They also do not establish a particular vial, concentration or quantity. Converting the daily headline into a presumed subscription price would supply information the pages do not provide.
The homepage also displays a 40% discount for the two injectable weight-loss offerings, but the reviewed material does not explain the reference price, promotional duration, eligibility conditions or whether discounts combine. Refills says costs depend on the specific medicine, prescribed plan and state availability. Separately, its homepage says all dosages have the same low price and that dosage changes do not change the charge. Those broad statements still leave the actual initial and subsequent checkout amounts to be confirmed.
There is another distinction between marketing and contract language. The homepage promises no monthly membership or app fees, while the terms say the total subscription price includes applicable pharmacy charges, professional-service charges and platform-access fees. That does not establish an extra fee beyond the quoted total, but it leaves the relationship between those descriptions unresolved. Request an itemized written GLP-1 quote, including whether any ordered laboratory work is included; concrete laboratory charges are not documented.
Who owes you which part of the service?
The terms identify Refills Health LLC as the operator of the websites and digital services. Refills says it is not a medical services provider and instead connects users with independent, licensed clinicians through partners such as Beluga Health, Bask Health, Wasef Health and TelegraMD. The terms expressly name Wasef Health, P.C. among the professional entities involved. These are provider descriptions, not independent verification of individual clinicians’ credentials or of which entity will handle a particular enrollment.
Refills also says completing its assessment does not create a clinician–patient relationship with Refills Health. Prescribing decisions belong to the clinician, rather than the platform or its advertising flow. The intake collects health history, lifestyle information and weight-management goals; a clinician reviews that information and may order laboratory testing. The contractual point is that access to a platform and payment for a service should not be mistaken for a guaranteed prescription or a predetermined medication choice.
Ask the service to identify your clinical entity and dispensing pharmacy once assigned, and retain their contact details separately from the platform’s billing channel. That makes it easier to direct a prescription question, account dispute or delivery problem to the responsible party. Our explanation of platform, clinician and pharmacy responsibilities offers a framework for reading this arrangement. Refills’ division of roles is documented, but the reviewed pages do not establish a single response deadline covering all three.
Product names and pharmacy choice need precision
The GLP-1 product page identifies compounded semaglutide and presents an injectable offering. The Personalized GIP + GLP-1 page describes a clinician-guided injection plan but does not identify its specific active ingredient in the reviewed description. The FAQ mentions semaglutide-based and liraglutide-based options as category examples; that is not confirmation that every named medicine is available to every customer. A useful enrollment answer should specify the actual prescribed preparation, route, presentation and dispensing pharmacy, rather than repeat a broad product category.
Refills says its GLP-1 medicines come exclusively from U.S. pharmacies and that a compounded medicine may be prescribed when a partner clinician considers it medically appropriate. Its partner page names Perfect Rx Pharmacy, legally PERFECTRX LLC, in Bartonville, Texas, and Hallandale Pharmacy, operated by Pharmcore, Inc., in Fort Lauderdale, Florida. The terms list a wider network that also includes Greenwich Pharmacy, VialsRx and The Pharmacy Hub. Being named in that network does not identify which pharmacy will dispense a particular order.
Importantly, the terms allow a prescription to be filled through an accessible network pharmacy or sent to a pharmacy chosen by the patient. They do not establish the price, product availability or shipping arrangements for that alternative. Ask how outside-pharmacy fulfillment affects the subscription and its bundled charges. Refills also claims batch purity and potency testing and says patients may request a Certificate of Analysis. No actual certificates were available in the reviewed documentation, so those remain attributed quality claims rather than independently checked findings.
Eligibility, geography and insurance are separate gates
The terms require users to be at least 18 and located in the United States. Refills describes clinical review of BMI and weight history, weight-related conditions, current medicines, contraindications and previous weight-loss efforts, without establishing a numerical BMI threshold in the reviewed eligibility description. Its product page also identifies medical-history screening that may affect eligibility. These are reasons to complete an accurate clinical assessment, not grounds for assuming that meeting the age requirement guarantees access or approval.
Geographic descriptions are inconsistent. The homepage says Refills operates in all 50 states but does not serve the District of Columbia. The terms include both all 50 states and the District. The FAQ is narrower in another way: it says shipping reaches most states and availability varies with product and pharmacy regulations, while clinical review depends partly on state coverage. Before paying, obtain confirmation for your location and exact product; a broad nationwide statement does not settle these differences.
Insurance wording also needs reconciliation. Advertising says insurance is not required, but the terms go further: neither the customer nor the participating entities may seek or receive reimbursement from federal, state or private healthcare payors for services or products through this pathway. The FAQ nevertheless suggests insurance might apply to a specific medication or fulfillment route. Ask whether such a route is separate from the self-pay service and request its terms before assuming you can submit a receipt for reimbursement.
Delivery promises begin after other work is finished
Refills describes a fully virtual process without required in-person visits. Its FAQ says requests are often reviewed within hours, depending on demand and state coverage, whereas the homepage places the initial consultation typically within a few days of signup. Those statements describe different stages and should not be collapsed into one guaranteed turnaround. Neither provides a complete signup-to-delivery schedule, particularly when further information or laboratory testing is needed before a clinician can make a prescribing decision.
For shipping, the FAQ says most orders arrive within three to five business days after prescription approval and pharmacy processing. That is an arrival estimate with prerequisites, not a promise of delivery three to five days after enrollment. Refills says tracking becomes available when an order ships and describes plain, unbranded outer packaging. Although product pages advertise free shipping, the FAQ specifies free shipping on most subscription refills; it does not establish that every shipment under every arrangement is free.
The reviewed documentation does not identify the carrier, pharmacy-processing duration, cold-chain arrangements or replacement and refund rules for lost packages. The terms also warn that pharmacy products may not come in child-resistant packaging or containers. These are meaningful details to resolve before a first shipment, especially if a delivery concern could overlap with a renewal. For injectable GLP-1 products arriving warm or inadequately refrigerated, FDA explicitly advises not using the product and contacting the provider or dispensing pharmacy.
Ongoing access is not the same as a defined clinical schedule
Refills’ process page promises ongoing dashboard access to a Care Team for questions and treatment follow-up. The FAQ says a full consultation is not necessarily repeated every month; subscriptions may instead use clinician involvement at appropriate check-in points. New symptoms, treatment changes, medical history or laboratory needs may prompt additional review. Its weight-management page also describes clinician-supported transition to maintenance. Together, these describe continuity, but they do not establish a uniform appointment schedule or mandatory frequency for every plan.
The homepage advertises free 24/7 Health Concierge support. The FAQ draws a useful boundary: administrative issues such as account access, shipping and billing go through site contact options, while medical questions should use the clinical messaging pathway or portal if available under the plan. A continuously available concierge is therefore not documented as an immediately available clinician. Ask which medical channel your purchase includes, whether any services cost extra, and what response expectations apply outside ordinary business hours.
The contact page lists support at (888) 458 5061 and an address at 1401 Pennsylvania Avenue, Suite 105, Wilmington, Delaware 19806. Those are practical administrative contact paths, not evidence of an in-person treatment location. The reviewed material does not confirm Spanish-language care, interpreters or Spanish clinical forms. Refills’ privacy policy also says it collects sensitive health and medication information, including weight-management and reproductive or sexual-health information. Read that disclosure before submitting an intake, rather than treating it as ordinary shopping data.
Refund boundaries and medical claims remain separate questions
The reviewed documentation does not establish the content of a refund or returns policy. Consequently, it does not support a promise that canceling produces a refund, that a declined prescription triggers a particular repayment, or that a shipment problem will be resolved in a specified way. The FAQ’s no-penalty cancellation language does not answer those questions. Request the applicable policy before payment, including its treatment of clinical-review charges, pharmacy processing and already-dispensed medication. Our guide to refund boundaries explains the distinctions to look for.
Refills discloses that compounded products are not FDA approved or evaluated by FDA for safety, effectiveness or quality. FDA’s guidance recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, and it neither validates nor condemns Refills. Likewise, clear subscription terms or a claimed quality-testing program cannot establish clinical outcomes for this platform’s patients.
FDA has also received reports of measuring or administration errors involving compounded GLP-1 medicines, some associated with hospitalization. That is general regulatory context, not a Refills-specific event rate. Instructions should be clarified with the prescriber or pharmacist rather than reconstructed from a review. The same separation applies to payment: a settled billing question does not resolve a medical concern, and ongoing charges do not establish that follow-up has occurred. Confirm both the commercial process and the clinical pathway before treating enrollment as complete.
Questions & answers
Does Refills’ $5-a-day advertisement tell me my monthly charge?
No. Both injectable plan pages use starting-at language, but the reviewed advertisements do not establish a billing total, period, supply quantity or commitment. Refills says pricing depends on the medicine, prescribed plan and state availability. Ask for the first charge and subsequent recurring charges separately, including their dates and included services. The homepage’s same-price-across-dosages statement does not fill in those missing purchase details or establish the duration of the advertised promotion.
Can I cancel Refills immediately before my next charge?
Do not rely on the FAQ’s anytime-cancellation wording for that situation. The terms specify cancellation up to 72 hours before the applicable monthly processing date, using email or app.refills.com. Ask support how a request inside that window affects the next payment and any pending pharmacy order. The documentation reviewed does not establish that cancellation reverses an existing charge or creates a refund, so obtain confirmation of both cancellation status and any separate refund decision.
Can I send a Refills prescription to my own pharmacy?
The terms expressly allow customers to choose a network pharmacy or have an issued prescription sent to a pharmacy of their choice. That does not guarantee that the outside pharmacy can supply the prescribed preparation, nor does it establish an outside-pharmacy price. Before choosing that route, ask how medication charges, professional charges, platform fees and future renewals will be handled. The option concerns an issued prescription; it does not guarantee that a clinician will prescribe.
Can I use insurance or seek reimbursement afterward?
The terms describe a direct-pay arrangement and prohibit seeking or receiving reimbursement from federal, state or private healthcare payors for this pathway’s products and services. The FAQ nevertheless suggests insurance could be involved in certain medication or fulfillment routes. Those statements need written reconciliation for the exact route offered to you. Insurance not being required is not the same as insurance being accepted, and the FAQ should not be treated as blanket permission to submit a claim.
Is Refills available in Washington, D.C.?
The consulted pages do not give a consistent answer. The homepage expressly excludes the District of Columbia, while the terms include it alongside all 50 states. The FAQ also conditions availability on the treatment and pharmacy rules. A D.C. resident should obtain specific confirmation before paying or completing enrollment. Customers elsewhere should likewise confirm the actual medicine and clinical coverage for their location, rather than assuming the broad geographic claim guarantees every offering.
Does free 24/7 support mean I can reach a clinician immediately?
That is not established. Refills advertises free 24/7 Health Concierge support, but its FAQ separates administrative support from medical questions and makes clinical portal messaging conditional on the plan. Ask which clinical contact channel you receive, what response times apply and whether additional consultations carry charges. For billing, account or shipping issues, the contact page lists (888) 458 5061. A support number and an always-available concierge do not establish an immediate clinical response.
Our assessment
Refills documents several useful features: a virtual intake, independent clinical decision-making, named pharmacy relationships, an outside-pharmacy prescription option and dashboard-based subscription management. Its terms also disclose automatic renewal and a specific cancellation cutoff. The weakness is the gap between those details and broader marketing promises. A starting daily price does not establish the purchase total; anytime cancellation needs the 72-hour qualification; insurance and geographic descriptions conflict; and refund boundaries remain undocumented in the reviewed material. Before authorizing payment, obtain a written quote, the next processing date, the applicable refund policy, confirmation of state and product availability, and the identities of the clinical and pharmacy entities. Refills can be evaluated as a documented access platform, but its public pages alone are not enough to settle the financial and service obligations of an individual subscription.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Refills / Refills Health — privacy policy ↗
- Refills / Refills Health — official website ↗
- Refills / Refills Health — faq ↗
- Refills / Refills Health — terms conditions ↗
- Refills / Refills Health — our pharmacy partner ↗
- Refills / Refills Health — weight loss ↗
- Refills / Refills Health — weight loss/personalized glp 1 injection ↗
- Refills / Refills Health — weight loss/personalized gip glp 1 injection ↗
- Refills / Refills Health — how refills works ↗
- Refills / Refills Health — contact ↗